Targeting Multiple Immune Checkpoints with a Single Checkpoint Inhibitor: Implications for Immunotherapy Against CNS Cancer.
|Effective start/end date||8/1/19 → 7/31/20|
- THE MUSELLA FOUNDATION FOR BRAIN TUMOR
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.